CSI Market
Sign In | Register

Baudax Bio Inc (BXRX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BXRX quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Baudax Bio Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-58.80
Depreciation & amortization0.17
Amortization of Other Assets2.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset-2.76
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase5.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation1.40
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.01
Increase Decrease In Right Of Use Asset-
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities-1.30
Noncash Or Part Noncash Acquisition Fixed Assets Acquired0.01
Loss On Impairment Of Construction In Progress4.16
Non Cash Interest Expense1.02
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.21
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.44
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities19.68
Discontinued operations0.00
Net Cash flow from Operating Activities-27.79
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Payments to Acquire Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments For Acquisition Of License Agreement-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale and Maturity of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.21
Long-term debt - borrowings0.00
Long-term debt - repayments-2.24
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock19.07
Proceeds from Contributions from Parent0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.20
Proceeds From Equity Facility Net Of Transaction Costs-
Proceeds From Registered Direct Offerings Net Of Transaction Costs1.76
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities17.18
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-27.81
Total Cash Flow-10.63
4 historic quarters locked

Sign in to unlock the full Baudax Bio Inc cash flow history.

Sign In Create Free Account

About Baudax Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-065200

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License